Abstracts - faqs.org

Abstracts

Chemistry

Search abstracts:
Abstracts » Chemistry

DNA cross-linking agents as antitumor drugs

Article Abstract:

DNA interstrand cross-linking compounds are used as clinical agents in the treatment of cancers and other medical disorders such as anemia and skin diseases. They are capable of inhibiting DNA strand separations which are vital in replication and transcription. The compounds are significant in the technique of selective drug activation through protein overexpression. The major groups of the compounds are inherently reactive agents, photoactivated cross-linking agents, oxidatively activated agents and hypoxia-selective agents.

Author: Williams, Robert M., Rajski, Scott R.
Publisher: American Chemical Society
Publication Name: Chemical Reviews
Subject: Chemistry
ISSN: 0009-2665
Year: 1998
DNA, Cancer, Proteins, Protein crosslinking, Chemotherapy, Crosslinked polymers, Polymer crosslinking

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Interactions of antitumor metallodrugs with serum proteins: Advances in characterization using modern analytical methodology

Article Abstract:

Serum proteins play a crucial role in the transport, delivery and mechanism of action of anticancer metal-containing drugs, and efficient and convenient analytical methods for a better understanding of their functions help further in developing antitumor metallodrugs. Various aspects of protein -metallodrug binding studies are studied and the potential and utilization of conventional and advanced analytical techniques in this growing-in-importance area are critically examined.

Author: Timerbaev, Andrei R., Hartinger, Christian G., Aleksenko, Svetlana S., Keppler, Bernhard K.
Publisher: American Chemical Society
Publication Name: Chemical Reviews
Subject: Chemistry
ISSN: 0009-2665
Year: 2006
Blood serum, Active sites (Biochemistry), Structure, Chemical properties

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Current status of platinum-based antitumor drugs

Article Abstract:

Researchers continue to develop newer types of platinum-based drugs for treating cancer. The most widely use platinum cancer drug is cisplatin, but it has severe side effects and can only be used for certain tumors. Many tumors also become resistant to the drug.

Author: Wong, Ernest, Giandomenico, Christen M.
Publisher: American Chemical Society
Publication Name: Chemical Reviews
Subject: Chemistry
ISSN: 0009-2665
Year: 1999
Health aspects, Inorganic compounds, Cisplatin

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Antineoplastic agents
Similar abstracts:
  • Abstracts: Domino reactions in organic synthesis. Stereocontrolled synthesis of tetrasubstituted olefins. Enantioselective palladium-catalyzed transformations
  • Abstracts: Folding and stability of alpha-helical integral membrane proteins
  • Abstracts: BINOL: A versatile chiral reagent. Concurrent tandem catalysis. Natural occurrence, syntheses and applications of cyclopropyl-group-containing [alpha]-amino acids. 2. 3,4- and 4,5-methanoamino acids
  • Abstracts: Treatment of substitution and rearrangement mechanisms of transition metal complexes with quantum chemical methods
  • Abstracts: Structure-function relationships of alternative nitrogenases. Mechanistic studies on synthetic Fe-S-based clusters and their relevance to the action of nitrogenases
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.